{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:42:39Z","timestamp":1785321759796,"version":"3.55.0"},"reference-count":38,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH3DA043231"],"award-info":[{"award-number":["UH3DA043231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment\u2010seeking individuals with CUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A phase 2, randomized, double\u2010blind, parallel group, placebo\u2010controlled trial was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Two outpatient research clinics in South Carolina, USA, from February 2020 to February 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Eligible participants met\n                      <jats:italic>Diagnostic and Statistical Manual of Mental Disorders<\/jats:italic>\n                      , Fifth Edition (DSM\u20105) criteria for CUD and used cannabis a minimum of 3\u00a0days per week. One hundred and seventy\u2010four participants were randomized to either varenicline (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200990) or placebo (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200984) stratified by smoking status and sex.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Varenicline (titrated to goal dose of 1\u00a0mg twice daily) or matching placebo for 12\u2009weeks. Medical management was provided weekly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>Primary outcome measure was reduction in total number of cannabis use sessions at each weekly visit (weeks 6\u201312).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      There was no main effect of treatment on reduction of total number of cannabis use sessions per week during weeks 6 through 12 [between group difference (\u0394)\u2009=\u20091.7; 95% confidence interval (CI)\u2009=\u2009\u22121.0 to 4.7;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.41]; however, a statistically significant treatment by sex interaction was found (F\n                      <jats:sub>1,132<\/jats:sub>\n                      \u2009=\u20095.1;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.026), with a statistically significant effect of varenicline on reduction of cannabis use sessions per week observed in men (\u0394\u2009=\u20094.2; 95% CI\u2009=\u20090.6\u20137.8;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04) but not women (\u0394\u2009=\u2009\u22121.4; 95% CI\u2009=\u2009\u22125.7 to 3.0;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.18).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Varenicline with medical management resulted in decreased cannabis use among men with cannabis use disorder seeking treatment, but not women (no effect was observed on the overall sample of treatment\u2010seeking individuals with cannabis use disorder).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.70296","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:01:09Z","timestamp":1768453269000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Varenicline for cannabis use disorder: A randomized controlled trial"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9774-318X","authenticated-orcid":false,"given":"Aimee L.","family":"McRae\u2010Clark","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston SC USA"},{"name":"Ralph H. Johnson VA Medical Center  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3313-1579","authenticated-orcid":false,"given":"Nathaniel L.","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences Medical University of South Carolina  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8097-3061","authenticated-orcid":false,"given":"Brian J.","family":"Sherman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Tolliver","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Burt","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonzo","family":"Steplight","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Chapman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"Substance Abuse and Mental Health Services Administration.Results from the 2022 National Survey on Drug Use and Health: Detailed tables. Accessed April 10 2024.https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-detailed-tables"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1465398"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.05.008"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1747"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.47.120505.105214"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(00)00371-7"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.025130"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.070256"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.47"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.56"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.11.001"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3518-1"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.01.029"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2160-9"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2717-x"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e31829623f4"},{"key":"e_1_2_10_18_1","first-page":"129","article-title":"Effect of varenicline combined with medical management on alcohol use disorder: a randomized clinical trial","volume":"75","author":"O'Malley SS","year":"2018","journal-title":"JAMA"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106746"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109111"},{"issue":"20","key":"e_1_2_10_21_1","first-page":"22","article-title":"The Mini\u2010international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM\u2010IV and ICD\u201010","volume":"59","author":"Sheehan DV","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_10_22_1","volume-title":"Timeline follow\u2010back: a technique for assessing self\u2010reported alcohol consumption. Measuring alcohol consumption: psychosocial and biochemical methods","author":"Sobell LC","year":"1992"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.08.013"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.04.020"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.06.003"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.967102312.x"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10111704"},{"key":"e_1_2_10_28_1","first-page":"1185","article-title":"PROMIS\u201029 v2.0 profile physical and mental health summary scores","volume":"27","author":"Hay RD","year":"2018","journal-title":"Qual Life Res"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-022-00441-3"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2001.00120.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntv207"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1037\/0893-164X.21.2.216"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(00)00148-3"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-0167.45.3.265"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204260903900310"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/can.2016.0010"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107993"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230508"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.11.1967"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.70296","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.70296","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.70296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:01:14Z","timestamp":1768453274000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.70296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":38,"alternative-id":["10.1111\/add.70296"],"URL":"https:\/\/doi.org\/10.1111\/add.70296","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"2025-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"add.70296"}}